Endonovo Therapeutics (ENDV) SEC Filings & 10K Form

$0.0025
0.00 (0.00%)
(As of 05/9/2024 ET)

Recent Endonovo Therapeutics SEC Filings

DateFilerForm TypeView
02/02/2024
4:23 PM
Endonovo Therapeutics (Filer)
Form 15-12G
01/03/2024
4:30 PM
Endonovo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
2:20 PM
Endonovo Therapeutics (Filer)
Form 10-Q/A
12/28/2023
7:50 PM
Endonovo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/04/2023
8:08 AM
Endonovo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
11:21 AM
Endonovo Therapeutics (Filer)
Form NT 10-Q
10/12/2023
5:03 AM
Endonovo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
6:04 AM
Endonovo Therapeutics (Filer)
Form 1-A/A
08/21/2023
4:16 PM
Endonovo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/14/2023
1:27 PM
Endonovo Therapeutics (Filer)
Form 1-A/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (OTCMKTS:ENDV) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners